American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

July 14, 2022

Newsletter Sponsor

Formulation – a game-changer

Whether it’s innovative new therapeutic modalities or a supplier suddenly falling out of regulatory compliance, disruptions come in known challenges and unexpected obstacles. Control allows you to decide the shape that disruption takes. With a portfolio of over 400 excipients, formulation technologies, and global regulatory expertise, MilliporeSigma changes the rules on disruption, giving you greater formulation control.

	Industry News

FDA Authorizes Pharmacists to Prescribe Paxlovid (nirmatrelvir and ritonavir) with Certain Limitations
The FDA revised the Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to ... read more »

Biolexis and Akston Biosciences Announce Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine
Akston Biosciences Corporation and Biolexis, a Strides Group Company, announced results from a Phase... read more »

AstraZeneca To Acquire TeneoTwo and Its Clinical-Stage T-Cell Engager, Strengthening Hematological Cancer Pipeline
AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo), including its Phase I ... read more »

Mogrify and Astellas to Collaborate on in vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss
Mogrify Limited and Astellas Pharma Inc. have executed a collaborative research agreement on in vivo... read more »

	QC Corner

Robotics and Automation: The Future of Pharma QC
Watch Now! The pharmaceutical industry is evolving towards automated, intensified and real-time-... read more »

	Infographic

Infographic: Co-processed Excipients Vs. Individually Blended Excipients
Co-processed Excipients Vs. Individually Blended Excipients
Download this infographic to see the top five reasons why co-processed excipients are inherently better than their individually blended counterparts. read more »

	Featured Articles

Improved Drug Stability Stored in Lubricant-Free Hybrid Syringes A sterile, high-dose accuracy, low injection volume syringe was developed for a Novartis ophthalmic drug to treat retinopathy prematurity [1,2], which... read more »

Read Article: The Promise and Challenges of mRNA Vaccine Development Decades of research led to the development of the first mRNA vaccine that has changed the course of the Coronavirus Disease 2019 (COVID-19) Pandemic. ... read more »

	Featured Video

Watch Video: Cell and Gene Technologies at Lonza
Cell and Gene Technologies at Lonza watch »

On-Demand Webinar: FT-NIR Applied to Bioprocess Monitoring in a cGMP Environment
In this webinar, learn how FT-NIR is applied to Bioprocess Monitoring in a cGMP Environment. watch »

	Featured Products

BIOne Single-Use Fermentor
read more »

Remote Particle Counter: IsoAir® Pro-Plus
read more »

EZ-Accu Shot™ Growth Promotion Test
read more »

	Featured Whitepaper

eBook: Guidance for Cell and Gene Therapy Manufacturing - Meeting GMP and Regulatory Challenges
As biopharmaceutical manufacturers embrace new technologies, mycoplasma testing continues to present challenges at various stages in the production process for cell therapy products. Risk assessment ... read more »

App Note: Cubis® II Lab Balance in the Context of Therapeutic Antibodies
Antibodies are subject to instability issues due to chemical and physical instabilities. Oxidation, disulfide bond formation, Glycation and Deamidation are the most frequent chemical instabilities ... read more »

	Events

Pre-Filled Syringes San Francisco
San Francisco, CA – 09/19/2022
The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-... event details »

SAE Media Group’s 2nd Annual Biosensors for Medical Wearables
Boston, MA – 10/24/2022
Advances in development and therapeutic applications of on-body sensors SAE Media Group is proud to present the Biosensors for Medical Wearables ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA